Phase IIIAndrogen Modulator
Compound 62186
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-062186
Risk Class
HIGH
Last Audit
Feb 17, 2109
Research Abstract
Androgen Modulator candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 62186 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in phase iii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-062186 with updates logged 2109-02-17.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-62186Androgen Modulator Program 62186
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-062186
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-62186